Get started
Author

Lidia Gurba-Bryśkiewicz

Observed names: Gurba Lidia, Gurba-Bryśkiewicz, Lidia, Lidia Gurba
ORCID: 0000-0002-7807-6641
Observed ORCID: 0000-0002-7807-6641
OpenAlex ID: A5047764683
Quality by Design (QbD) and Design of Experiments (DOE) as a Strategy for Tuning Lipid Nanoparticle Formulations for RNA Delivery
2023 · Lidia Gurba-Bryśkiewicz, Wioleta Maruszak, et al. · Biomedicines · 72
PDF
Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists
2021 · Piotr Pankiewicz, Marcin Szybiński, et al. · Pharmaceuticals · 42
PDF
Implementation of QbD Approach to the Development of Chromatographic Methods for the Determination of Complete Impurity Profile of Substance on the Preclinical and Clinical Step of Drug Discovery Studies
2022 · Lidia Gurba-Bryśkiewicz, Urszula Dawid, et al. · International Journal of Molecular Sciences · 17
PDF
Use of Ubp1 protease analog to produce recombinant human growth hormone in
2014 · Wojtowicz-Krawiec Anna, Sokolowska Iwona, et al. · Microbial Cell Factories · 16
Discovery and development of CPL207280 as new GPR40/FFA1 agonist
2021 · Mateusz Mach, Katarzyna Bazydło-Guzenda, et al. · European Journal of Medicinal Chemistry · 15
Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II—Benzimidazole Derivatives
2022 · Mariola Stypik, Stanisław Michałek, et al. · Pharmaceuticals · 11
PDF
Results from Genetic Studies in Patients Affected with Craniosynostosis: Clinical and Molecular Aspects
2022 · Ewelina Bukowska-Olech, Anna Sowińska-Seidler, et al. · Frontiers in Molecular Biosciences · 11
The design of experiments (DoE) in optimization of an aerobic flow Pd-catalyzed oxidation of alcohol towards an important aldehyde precursor in the synthesis of phosphatidylinositide 3-kinase inhibitor (CPL302415)
2022 · Stanisław Michałek, Lidia Gurba-Bryśkiewicz, et al. · RSC Advances · 9
PDF
Expression of recombinant human bifunctional peptidylglycine α-amidating monooxygenase in CHO cells and its use for insulin analogue modification
2015 · Marcin Zieliński, Anna Wójtowicz-Krawiec, et al. · Protein Expression and Purification · 7
Design, Synthesis, and Development of pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part I—Indole Derivatives
2022 · Mariola Stypik, Marcin Zagozda, et al. · Pharmaceuticals · 4
PDF
Development and optimization of a continuous flow ester reduction with LiAlH 4 in the synthesis of a key intermediate for a PI3Kδ inhibitor (CPL302415)
2023 · Stanisław Michałek, Anna M. Maj, et al. · Reaction Chemistry & Engineering · 3
Tuning the Biological Activity of PI3Kδ Inhibitor by the Introduction of a Fluorine Atom Using the Computational Workflow
2023 · Wojciech Pietruś, Mariola Stypik, et al. · Molecules · 2
PDF
Fast Claisen condensation reaction optimization in a continuous flow reactor
2023 · Stanisław Michałek, Antoni Powała, et al. · Monatshefte für Chemie - Chemical Monthly · 1
PDF
CCDC 2076005: Experimental Crystal Structure Determination
2021 · Mach, Mateusz, Bazydło-Guzenda, Katarzyna, et al. · The Cambridge Structural Database · 1
Development of the telescoped flow Pd-catalyzed aerobic alcohol oxidation/reductive amination sequence in the synthesis of new phosphatidylinositide 3-kinase inhibitor (CPL302415)
2024 · Stanisław Michałek, Anna M. Maj, et al. · RSC Advances
PDF
Works count: 15
Citation count: 211
H-index: 8
I10-index: 7
Year
Topic
Type